Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONVICT: Varenicline + Nicotine Patch for Smoking Cessation
NCT01184664Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Apr 2011
- Primary completion
- Oct 2011
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotine patch in tobacco dependence, sponsored by Queen Mary University of London. Started Apr 2011; status: completed.
02
Drugs
nicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT01184664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184664.